Billions for biotech

Written byEdyta Zielinska

| 1 min read

Maryland Governor Martin O'Malley announced his proposal to invest $1.1 billion in biotech industry, which could trump the $1 billion already signed by Massachusetts Governor Deval Patrick on Monday (June 16). Now the race for the biggest biotech hub on the east coast begins in earnest. Maryland's proposal, which O'Malley discussed during a visit to Johns Hopkins University yesterday, would allot funds for a biotechnology center, start-up companies, and $20 million annually for stem cell research. "We certainly see manufacturing has been on the decline in the past, and life sciences are really the new manufacturing for the 21st century." Donald C. Fry, president of the Greater Baltimore Committee told linkurl:__The Baltimore Sun.__;http://www.baltimoresun.com/news/health/bal-bioscience0616,0,6308709.story The bill may face some resistance in the state legislature, which downgraded a $23 million allotment for stem cells to $19 million this year. One of the provisions of the Massachusetts biotech bill will support young scientists with grants ranging from $5,000 to $15,000, to offset the low income of academic scientists in training. The program was named the Dr. Judah Folkman Higher Education Grant Fund, in honor of the cancer researcher and physician who linkurl:inspired many;http://www.the-scientist.com/blog/display/54173/ in the life sciences. "One of Judah's greatest gifts and passions was identifying brilliant young scientists and supporting and investing in them during the early part of their careers," said James Mandell, president and CEO of Children's Hospital Boston, linkurl:in a statement.;http://www.boston.com/news/health/blog/2008/06/life_sciences_b.html

Billions for biotech

The Scientist ARCHIVES

Become a Member of

Meet the Author

Edyta Zielinska

Related Research Resources

What Causes an Earworm?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Screening 3D Brain Cell Cultures for Drug Discovery

Multiplexing PCR Technologies for Biopharmaceutical Research

Products

Product News

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA